Medication use as a surrogate marker of emotional health in long-term cancer survivors
Menée aux Etats-Unis auprès de 225 patients ayant survécu plus de 5 ans à un cancer et auprès de 3 953 témoins, cette étude analyse leur utilisation de médicaments psychotropes
Evaluation of the pattern of psychiatric medications used by long-term cancer survivors is an inadequate surrogate marker with which to gauge survivors' emotional health. Specialty-level assessment and treatment are important for precise differential diagnosis and treatment when central nervous system disease recurrence can mimic psychiatric symptoms.
Cancer , éditorial, 2013